See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2018_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 46,924,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,365,000 |
| 3 | remainder_Assets | 5,597,000 |
| 4 | LiabilitiesCurrent | 19,258,000 |
| 5 | LiabilitiesNoncurrent | 19,044,000 |
| 6 | remainder_Liabilities | 494,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,373,101 |
| 9 | ResearchAndDevelopmentExpense | 9,897,393 |
| 10 | remainder_Expenses | -817,420 |
| 11 | remainder_Revenues | 38,549,855 |
| 12 | remainder_NetIncome | -1,668,482 |
| 13 | remainder_ComprehensiveNetIncome | 749,470 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 54,886,000 |
| 1 | Liabilities | 38,796,000 |
| 2 | Expenses | 33,453,074 |
| 3 | Revenues | 38,549,855 |
| 4 | StockholdersEquity | 16,090,000 |
| 5 | NetIncome | 3,428,299 |
| 6 | ComprehensiveNetIncome | 3,803,034 |
| 7 | BaseVar | 84,051,440 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.830 |
| 9 | EconomicCapitalRatio | 2.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
